Welcome to our dedicated page for Cycurion news (Ticker: CYCU), a resource for investors and traders seeking the latest updates and insights on Cycurion stock.
Cycurion, Inc. reports developments in AI-driven cybersecurity, information technology security services, and government technology solutions. The company provides advisory consulting, managed security services, SaaS cybersecurity tools, systems engineering, information assurance, risk management, and help desk support through subsidiaries including Axxum Technologies LLC, Cloudburst Security LLC, and Cycurion Innovation, Inc.
Recurring news themes include contract awards with government and enterprise customers, municipal and agency services under MSA and IDIQ arrangements, updates on the ARx platform and Cyber Shield managed security platform, backlog and recurring-revenue commentary, shareholder communications, capital-structure and operational initiatives, and litigation or market-integrity actions involving the company's public securities.
Summary not available.
Cycurion (Nasdaq: CYCU) announced a strategic, multi-year partnership with a Fortune 500 company to support a major U.S. government agency. The agreement has a minimum five-year term, and Cycurion’s portion is valued at approximately $1 million in year one, with potential expansion in later years.
The engagement will deliver AI-driven cybersecurity solutions, application transition and delivery services, and specialized AI implementation and infrastructure support, positioning Cycurion to deepen its AI footprint and pursue longer-term collaboration.
Summary not available.
Summary not available.
Cycurion (NASDAQ: CYCU) reported full-year 2025 results and a corporate update highlighting a structural transformation following its February 2025 public debut. Revenue was $15.1M in 2025 vs $17.8M in 2024; net loss was $23.7M. The company reduced net debt by over 70%, held >$5M cash, maintained a $112M contracted backlog (~4-year weighted life), and implemented $2.2M of annualized cost savings in early 2026 while investing in AI and its ARx platform.
Cycurion (Nasdaq: CYCU) won two public-health contracts expected to generate approximately $1.35 million in combined 2026 revenue, including $1.165 million in new annual recurring revenue (ARR).
The awards include a one-year task order under a potential 10-year framework with a large healthcare government agency and an expanded engagement with NACCHO, focused on secure cloud public-health systems, cybersecurity, resiliency, and cloud infrastructure.
Cycurion (Nasdaq: CYCU) said an unauthorized press release claiming an acquisition over $150 million was false and issued without company authorization on March 16–17, 2026. Cycurion notified FINRA and Nasdaq MarketWatch, engaged litigation counsel, obtained court subpoenas, and is using internal cybersecurity resources to investigate and protect communications.
The company cites a verified contracted backlog of $112.4 million, reports trading volatility tied to the false release, and urges reliance on verified Cycurion channels.
Cycurion (Nasdaq: CYCU) adjourned its special meeting of stockholders to March 19, 2026 at 12:00 p.m. ET to allow additional time for voting after an initial lack of quorum.
The meeting will vote on approval under Nasdaq Rule 5635(d) to issue up to 3,314,920 shares upon exercise of warrants from a December 5, 2025 private placement; the record date remains January 21, 2026.
Cycurion (Nasdaq: CYCU) announced a strategic reorganization on Feb 11, 2026 to streamline operations, enhance agility, and prioritize client-centered cybersecurity innovation. The company expects approximately $2.2 million of total annualized cost efficiencies in 2026 and appointed Rick Finfera as Chief Revenue Officer to drive global revenue growth.
Initiatives focus on cloud security, AI-driven risk management, infrastructure protection, and continued investment in the AI-powered ARx platform.
Cycurion (NASDAQ: CYCU) said Litchfield Hills Research initiated coverage with a Buy rating and a $7.00 price target on Jan 23, 2026, highlighting an $80 million contracted backlog roughly four times fiscal 2024 revenue of $15.67 million.
The release notes a micro-cap market capitalization of $10.68 million, shares down 78.2% over six months, a Price/Book of 0.53, and an estimated 2026 revenue multiple of 2.9x versus peers at 9.0x.